holdings2017bb – Page 7

Honorary Doctor of Commerce Degree conferred on Stephen Saad

April 11, 2014

10/04/14: [embedded content] Port Elizabeth – The Nelson Mandela Metropolitan University (NMMU) today conferred the degree of Doctor of Commerce (honoris causa) on Stephen Saad, Aspen Group Co-Founder and Chief Executive. Chancellor of the NMMU, Santie Botha said, ‘’It is an honour for NMMU to confer this honorary degree on Stephen Saad. His vision and…

Aspen’s half-year revenue increases to R12 billion

March 6, 2014

06/03/14: Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), the ninth largest generic company in the world and Africa’s largest pharmaceutical manufacturer, has announced excellent results for the six months ended 31 December 2013. Group Performance Revenue increased by 33% to R12.0 billion. Operating profit improved by 16% to R2.9 billion after absorbing…

First global program dedicated to Women with Cancer and Thrombosis launched

February 14, 2014

A Group of global experts in the field of thrombosis and cancer launched the Women Thrombosis Cancer (WTC) medical education initiative on 14 February 2015 at the 6th International Symposium on Women’s Health Issues in Thrombosis and Haemostasis (WHITH) in Berlin. (Berlin, Germany, 14 February 2015) “With more than 17 million women living with cancer*,…

Aspen’s growth formula

January 16, 2014

16/01/14: On a recent holiday to Disney World with his family, Aspen Pharmacare CE Stephen Saad wandered into a pharmacy while his children enjoyed the rides. On a shelf he found Murine Clear Eyes, the eye drops made at Aspen’s Port Elizabeth plant. “About 2m-3m packs a month are sold around the world but it…